Privately held FEops, headquartered in Gent, Belgium, has developed FEops HEARTguide™, a proprietary system to improve transcatheter valve procedures based on personalized computer simulations. “FEops HEARTguide™ is available on the European and Canadian market with indication for use in TAVI and LAAo and is currently the only technology on the market that predicts how a TAVI or LAAo implant will interact with the patient-specific anatomy and thus provide clinically meaningful insights in the personalized device size selection and position.” FEops’ pipeline extends to dedicated planning tools with unique potential in driving forward the development, testing and market adoption of new and improved device-based solutions in the structural heart space.
Location: Belgium, East Flanders, Zwijnaarde
Employees: 11-50
Total raised: $14.01M
Founded date: 2009
Investors 3
Funding Rounds 3
| Date | Series | Amount | Investors |
| 07.11.2022 | - | $3.29M | - |
| 10.12.2019 | Grant | $3.55M | - |
| 22.09.2017 | Series B | $7.17M | - |
Mentions in press and media 18
| Date | Title | Description |
| 31.07.2024 | Materialise expands on its medical portfolio with FEops’ acquisition | Join the Expert Committee for the 2024 3D Printing Industry Awards to help select the winners! 3D printing services and software company Materialise has acquired Belgian AI simulation specialist FEops for structural heart interventions. The... |
| 30.11.2022 | FEops’ AI-enabled Solution Changes TAVI Pre-procedural Decision in One Third of Patients | Data from the PRECISE-TAVI study, presented at the PCR Valves 2022 convention in London shows that Transcatheter Aortic Valve Implantation (TAVI) procedures planned by means of FEops HEARTguide result in an important change of pre-procedura... |
| 07.11.2022 | FEops Secures EUR 3.3M Convertible Loan From the EIC Fund | FEops, a Gent, Belgium-based a cloud-based digital health player in the structural heart space, raised s convertible loan of EUR 3.3M. Current investors and EIC Fund participated. The company intends to use the funds to continue spearheadin... |
| 01.11.2022 | Belgium’s FEops receives additional capital from EIC Fund to help treat structural heart disease patients | Gent, Belgium-based FEops, a digital health scale-up, announced on Friday, October 28th, that it has secured a convertible loan of €3.3M from its current investors and the EIC Fund, in preparation of a larger capital round. The funds will e... |
| 17.09.2022 | FEops AI-Enabled Solution Improves Outcomes for Heart Disease Patients | FEops HEARTguide significantly improves efficiency and outcomes of LAAO procedures in the PREDICT-LAA Randomized Clinical Trial Data from the PREDICT-LAA trial, presented at the Late-Breaking Innovation session at the TCT 2022 convention in... |
| 21.10.2021 | FEops appoints Digital Health expert Euan Thomson to its Board of Directors | Ghent, Belgium: 21 October 2021 – FEops, a cloud-based digital health player in the structural heart space, is glad to announce the nomination of Euan Thomson as a board member to its Board of Directors. |
| 14.10.2021 | FEops HEARTguide authorized by FDA for unprecedented LAAo planning capabilities | Ghent, Belgium: 14 October 2021 – FEops today announced that it received De Novo authorization from the U.S. Food and Drug Administration (FDA) for FEops HEARTguide™ pre-operative planning of left atrial appendage occlusion with the Boston ... |
| 04.07.2021 | 21 ways medical digital twins will transform healthcare | Did you miss a session from GamesBeat Summit 2022? All sessions are available to stream now. Learn more. The healthcare industry is starting to adopt digital twins to improve personalized medicine, healthcare organization performance, and n... |
| 04.07.2021 | 21 ways medical digital twins will transform health care | Where does your enterprise stand on the AI adoption curve? Take our AI survey to find out. The health care industry is starting to adopt digital twins to improve personalized medicine, health care organization performance, and new medicines... |
| 17.01.2020 | PREDICT-LAA trial enrolls first patient | Ghent, Belgium: 17 January 2020 – FEops, a leader in personalized predictive planning for structural heart interventions, is proud to announce that today the first patient has been enrolled in the physician-initiated PREDICT-LAA trial. The ... |
Show more